Kelley Boucher's most recent trade in Apellis Pharmaceuticals Inc was a trade of 45,766 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc | Kelley Boucher | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2025 | 45,766 | 45,766 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Kelley Boucher | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2025 | 30,476 | 97,658 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Kelley Boucher | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 67,396 | 67,396 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Kelley Boucher | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 45,095 | 67,182 (0%) | 0% | 0 | Common Stock | |
| Apellis Pharmaceuticals Inc | Kelley Boucher | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 32,976 | 32,976 | - | - | Stock Option (Right to Buy) | |
| Apellis Pharmaceuticals Inc | Kelley Boucher | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 22,087 | 22,087 (0%) | 0% | 0 | Common Stock |